Immunocore Holdings plc Research And Development Expense

• Immunocore Holdings plc showed an increase of +23.7% in Research And Development Expense from 2024 to 2025.
• This data is from Immunocore Holdings plc's annual report (Form 10-K), filed with the SEC on February 25, 2026.
• XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2018 to 2025), Immunocore Holdings plc's Research And Development Expense has grown by 228.9%.
• Historical annual values: Fiscal year 2025: $274.87 million | Fiscal year 2024: $222.15 million | Fiscal year 2023: $163.55 million | Fiscal year 2022: $101.92 million | Fiscal year 2021: $100.25 million | Fiscal year 2020: $74.81 million | Fiscal year 2019: $99.99 million | Fiscal year 2018: $83.58 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026